PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, ...

PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Franco Stevanato, CEO & Executive Chairman, reported that "for the fiscal 2025, total company revenue increased by 9% at constant-currency rates and 7% on a reported basis compared with 2024." He ...

PIOMBINO DESE, Italy--(BUSINESS WIRE)-- Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology ...

The latest price target for Stevanato Group (NYSE:STVN) was reported by Morgan Stanley on December 2, 2025. The analyst firm set a price target for $24.00 expecting STVN to rise to within 12 months (a ...

The company reiterated fiscal 2025 guidance, expecting revenue in the range of $1.16 billion to $1.19 billion, adjusted EBITDA between $288.5 million and $301.8 million, and adjusted diluted EPS ...

PIOMBINO DESE, Italy, June 25, 2020 /PRNewswire/ -- Italy-based Stevanato Group, a leading producer of pharmaceutical glass containers and integrated provider of drug delivery systems, and CEPI (the ...

Franco Stevanato commented, “On behalf of the Board of Directors and the Company, I would like to express my sincere gratitude to Mr. Moro for his valuable contributions to Stevanato Group. Over the ...